Resultados de la búsqueda

5 items
  1. event_combating_drug_trafficking

    Addressing Europe’s Drug Problem: Combating Drug Trafficking and Substance Misuse

    28 Octubre 2015 - Evento

    This International Symposium provides a timely opportunity for practitioners and stakeholders across Europe to discuss the latest challenges and consider the next steps needed to win the fight against illicit drug trafficking and substance misuse through holistic, multi-level and cross-border approaches. Public Policy Exchange welcomes the participation of all key partners, responsible authorities and stakeholders. The Symposium will support the exchange of ideas and encourage delegates to engage in thought-provoking topical debate.
     

  2. Global Experiences with Harm Reduction for Stimulants and New Psychoactive Substances

    20 Mayo 2014 - Evento

    The objective of this seminar is to compare the findings on innovative tools for the prevention of problematic cocaine use patterns, with experiences with harm reduction measures for stimu­lants in other regions of world.

  3. Expert Workshop on Supply-Oriented Harm Reduction

    10 Mayo 2011 - Evento

    The Washington Office on Latin America (WOLA) and the Transnational Institute (TNI) invited a group of 20 experts for a round-table discussion at the WOLA office in Washington DC . The main question on the table: can the concept of “harm reduction” be applied to supply-oriented challenges to better address the harms associated with illicit drug production and distribution, but also minimize the harms that stem from drug control itself?

  4. Thumbnail

    Randomized controlled trial of dexamphetamine maintenance for methamphetamine dependence

    • Marie Longo, Wendy Wickes, Matthew Smout, Sonia Harrison, Sharon Cahill, Jason M. White
    31 Mayo 2009
    Paper

    This study tested the impact of a long-acting form of amphetamine as medication to help control dependent use of the closely allied stimulant, methamphetamine. Prescribed usually for the treatment of pathological sleepiness or attention deficit/hyperactivity disorder, effects of the amphetamine tablets prescribed in the study take several hours longer to emerge than normal amphetamine and last three to six hours longer, giving it a 'smoothing' profile similar to methadone for heroin users; non-rapid onset make it less intensely pleasurable, and longer duration suits it to once-daily administration.